Submissions from 2022
The Food and Drug Administration's (FDA's) 510(k) Process: A Systematic Review of 1000 Cases, Puja Shah, Oscar Olavarria, Naila Dhanani, Hailie Ciomperlik, Cassandra Mohr, Karla Bernardi, Niharika Neela, Rainna Coelho, Zuhair Ali, Ajita Prabhu, and Mike K. Liang